| Line item | 2024-12-29 FY | 2023-12-31 FY | 2023-12-29 FY | 2023-01-01 FY | 2022-01-02 FY | 2021-01-03 FY |
|---|---|---|---|---|---|---|
| Revenue | $14.82M | $14.08M | $14.08M | $12.60M | $8.45M | $8.16M |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | $1.69M | $1.65M | $1.65M | $1.63M | $416.79K | $687.52K |
| Operating Income | -$1.83M | -$1.07M | -$1.07M | -$391.16K | $980.71K | $529.37K |
| Interest Expense | $99.91K | $97.61K | $97.61K | $114.77K | $172.86K | $177.76K |
| Tax Expense | $206.00K | $145.00K | -$145.00K | -$180.00K | $200.00K | $130.00K |
| Net Income | -$2.31M | -$887.37K | -$887.37K | -$562.28K | $607.85K | $791.99K |
| EPS (basic) | – | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – | – |